[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 71, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph Michael Redmond", "age": 62, "title": "President & Interim Principal Executive Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 9611}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 51, "title": "CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 314896, "exercisedValue": 0, "unexercisedValue": 4554}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer & Member of Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.oragenics.com/?q=investors", "maxAge": 86400, "priceHint": 4, "previousClose": 0.3199, "open": 0.3163, "dayLow": 0.317, "dayHigh": 0.3224, "regularMarketPreviousClose": 0.3199, "regularMarketOpen": 0.3163, "regularMarketDayLow": 0.317, "regularMarketDayHigh": 0.3224, "beta": 0.449, "forwardPE": -0.029129628, "volume": 188808, "regularMarketVolume": 188808, "averageVolume": 830678, "averageVolume10days": 637780, "averageDailyVolume10Day": 637780, "bidSize": 4000, "askSize": 800, "marketCap": 3438924, "fiftyTwoWeekLow": 0.29, "fiftyTwoWeekHigh": 7.74, "priceToSalesTrailing12Months": 460.6113, "fiftyDayAverage": 0.5738, "twoHundredDayAverage": 1.5958, "currency": "USD", "enterpriseValue": 1999788, "floatShares": 4717918, "sharesOutstanding": 10535900, "sharesShort": 197981, "sharesShortPriorMonth": 174440, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0188, "heldPercentInsiders": 0.0988, "heldPercentInstitutions": 0.11705, "shortRatio": 0.55, "shortPercentOfFloat": 0.0198, "impliedSharesOutstanding": 10931100, "bookValue": -0.048, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -19516236, "trailingEps": -7.33, "forwardEps": -10.8, "lastSplitFactor": "1:60", "lastSplitDate": 1674432000, "enterpriseToRevenue": 267.853, "enterpriseToEbitda": -0.102, "52WeekChange": -0.90801185, "SandP52WeekChange": 0.39389753, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "OGEN", "underlyingSymbol": "OGEN", "shortName": "Oragenics Inc.", "longName": "Oragenics, Inc.", "firstTradeDateEpochUtc": 1077719400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "747ffae6-a5e0-3f81-bef4-ef8201719134", "messageBoardId": "finmb_774436", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.3146, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 1348621, "totalCashPerShare": 0.242, "ebitda": -19638392, "quickRatio": 0.975, "currentRatio": 1.17, "totalRevenue": 7466, "revenuePerShare": 0.002, "returnOnAssets": -2.19891, "returnOnEquity": -4.5471897, "freeCashflow": -9515050, "operatingCashflow": -7214335, "operatingMargins": -2632.8518, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-28"}]